DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.7% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $422.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2026ACC: 0001310204-26-000014
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$422.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$140.96
Trade value
$422.88K
% of position
1.7%
4/15/2026
179.19K→176.19K
Total
Net shares
−3K
Net value
-$422.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | S · Sale | −3K | $140.96 | $422.88K | 1.7% | 179.19K | 176.19K |
| Total | −3K | -$422.88K | ||||||
Derivative Transactions0
No derivative transactions reported